Published: Feb 12, 2026
Written by Klarity Editorial Team
Published: Feb 12, 2026

If you’re struggling with Binge Eating Disorder (BED), telehealth has become an increasingly accessible way to receive treatment, including prescription medications. However, navigating the complex web of telehealth prescribing regulations can be confusing, especially with ongoing changes in both federal and state laws.
This comprehensive guide clarifies exactly what you need to know about getting BED medications like Topamax (topiramate) and Wellbutrin (bupropion) through telehealth services in 2026. Whether you’re wondering if you need an in-person visit, which healthcare providers can prescribe these medications, or what to expect during your telehealth journey, we’ve compiled the latest regulatory information and practical insights to help you access the care you need.
Before diving into state-specific regulations, it’s important to understand the federal framework:
Good news: For non-controlled medications like Topamax (topiramate) and Wellbutrin (bupropion) commonly used off-label for BED, federal law permits telehealth prescribing nationwide with no in-person requirement. These medications were never subject to the Ryan Haight Act restrictions that affect controlled substances.
This means that from a federal perspective, a qualified healthcare provider can evaluate you via telehealth and, if appropriate, prescribe these medications without ever needing to see you in person.
While this guide focuses on non-controlled medications, it’s worth noting that for controlled substances (like Vyvanse, which is FDA-approved for BED but is a Schedule II stimulant), the DEA has extended COVID-era flexibilities through December 31, 2026. This is the fourth extension while permanent rules are being finalized.
Even though federal law allows telehealth prescribing of non-controlled medications, states can impose their own additional requirements. Here’s what you need to know about key states:
In-person requirement: NoneProvider type: MD/DO, NP (independent after 3 years of experience)Special rules: California leads the nation in telehealth flexibility. A 2025 law (AB 1503) explicitly redefined a ‘good faith examination’ to include asynchronous telehealth, further expanding access.
In-person requirement: None for non-controlled medicationsProvider type: MD/DO, NP/PA (with physician delegation)Special rules: Texas allows most telehealth prescribing with video exams. While NPs need a prescriptive agreement with a physician, they can prescribe non-controlled medications like Topamax and Wellbutrin in any setting under delegation.
In-person requirement: None for non-controlled medicationsProvider type: MD/DO, NP (fully independent after 3,600 supervised hours)Special rules: While New York adopted rules in 2025 requiring in-person exams for controlled substances, non-controlled medications remain exempt from this requirement.
In-person requirement: None for non-controlled medicationsProvider type: MD/DO, NP (collaborative practice)Special rules: Florida’s telehealth law prohibits teleprescribing of most Schedule II drugs but has no in-person requirements for non-controlled medications like those used for BED.
In-person requirement: Periodic (within 12 months) if ongoing telehealth careProvider type: MD/DO, NP/PA (collaborative practice)Special rules: Georgia requires an attempt at an in-person exam at least annually for ongoing telemedicine care. Initial evaluation via telehealth is allowed if it’s equivalent to an in-person exam.
In-person requirement: Periodic (within 12 months) if more than 4 telehealth visits for the same conditionProvider type: MD/DO, NP (collaborative practice)Special rules: Alabama’s Telehealth Act requires that if you have more than 4 telehealth visits in 12 months for the same condition, you must see a provider in-person within that year (which can be satisfied by a collaborating provider on-site).
In-person requirement: NoneProvider type: MD/DO, NP (fully independent as of 2025 laws in both states)Special rules: Both states expanded NP practice authority in 2025 legislation. Neither state imposes special in-person requirements for telehealth prescribing of non-controlled medications.
Schedule: Non-controlled (legend drug)Telehealth prescribable: Yes, in all statesTypical max supply: 90-day supply with refills commonKey considerations:
Schedule: Non-controlled (legend drug)Telehealth prescribable: Yes, in all statesTypical max supply: 90-day supply; refills up to 1 yearKey considerations:
To receive BED medication via telehealth, you’ll need to meet the clinical criteria for Binge Eating Disorder. Providers will assess:
Be prepared to discuss your mental health history, previous treatments, and current symptoms in detail. At Klarity Health, our providers conduct thorough evaluations to ensure an accurate diagnosis and appropriate treatment plan.
Telehealth providers must document that:
Some situations may require in-person evaluation rather than telehealth:
At Klarity Health, our providers carefully screen for these contraindications to ensure patient safety.
Even though these medications are non-controlled, regular follow-up is important:
Medical Doctors (MDs) and Doctors of Osteopathy (DOs) can prescribe these medications in all states.
Nurse Practitioners (NPs) can also prescribe Topamax or Wellbutrin, but their level of autonomy varies by state:
Find the right provider for your needs — select your state to find expert care near you.